Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

被引：0
|
作者：
Eaton, D [1 ]
机构：
[1] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2006年 / 4卷 / 01期
关键词：
D O I：
10.1111/j.1538-7836.2005.01669.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：260 / 261
页数：2
相关论文
共 50 条
  • [41] Thrombin-mediated activation of factor XI results in a TAFI (thrombin activatable fibrinolysis inhibitor) dependent inhibition of fibrinolysis
    vondemBorne, PAK
    Bajzar, L
    Meijers, JCM
    Nesheim, ME
    Bouma, BN
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1177 - 1177
  • [42] Thrombin activatable fibrinolysis inhibitor
    Declerck, P. J.
    HAMOSTASEOLOGIE, 2011, 31 (03): : 165 - +
  • [43] Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis
    Lau, HK
    Segev, A
    Hegele, RA
    Sparkes, JD
    Teitel, JM
    Chisholm, RJ
    Strauss, BH
    THROMBOSIS AND HAEMOSTASIS, 2003, 90 (06) : 1187 - 1191
  • [44] Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukemia
    Meijers, JCM
    Oudijk, EJD
    Mosnier, LO
    Bos, R
    Bouma, BN
    Nieuwenhuis, HK
    Fijnheer, R
    THROMBOSIS AND HAEMOSTASIS, 1999, : 221 - 221
  • [45] An elevated thrombin activatable fibrinolysis inhibitor (TAFI) is a risk factor of recurrent venous thromboembolism
    Eichinger, S
    Schönauer, V
    Weltermann, A
    Schneider, B
    Kyrle, PA
    BLOOD, 2002, 100 (11) : 270A - 271A
  • [46] Decrements in the thrombin activatable fibrinolysis inhibitor (TAFI) levels in association with orlistat treatment in obesity
    Guven, Gulay Sain
    Kilicaslan, Alpaslan
    Oz, S. Gul
    Haznedaroglu, Ibrahim C.
    Kirazli, Serafettin
    Aslan, Dilek
    Soezen, Tuemay
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2006, 12 (03) : 364 - 368
  • [47] Thrombin activatable fibrinolysis inhibitor (TAFI) activity in plasma from patients with diminished endogenous thrombin generation
    Lucia D'Errico, Maria
    de Bosch, Norma
    Ruiz-Saez, Arlette
    Boadas, Apsara
    Ibarra, Carlos
    Maria Salazar, Ana
    Guerrero, Belsy
    INVESTIGACION CLINICA, 2019, 60 (02): : 128 - 140
  • [48] Thrombin activatable fibrinolysis inhibitor (TAFI) in human amniotic fluid. A preliminary study
    Uszynski, Waldemar
    Uszynski, Mieczyslaw
    Zekanowska, Ewa
    THROMBOSIS RESEARCH, 2007, 119 (02) : 241 - 245
  • [49] Thrombin-activatable fibrinolysis inhibitor (TAFI) is a potential biomarker for cerebral hemorrhage patients
    Wu, Botao
    Wen, Anyan
    Xu, Xuebin
    Zuo, Cheng
    Shan, Baochang
    Li, Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 2121 - 2127
  • [50] Thrombin activatable fibrinolysis inhibitor (TAFI) antigen: A novel predictor of angiographic coronary restenosis
    Lau, HK
    Teitel, JM
    Strauss, BH
    CIRCULATION, 2002, 106 (19) : 582 - 582
12345